Pioneering Drug Offers Hope to Prostate Cancer Sufferers - but Not for Three Years: Case Study:...

Posted on: Tuesday, 22 July 2008, 06:00 CDT By Lyndsay Moss SIMON Bush was first diagnosed with aggressive prostate cancer in 2005. Radiotherapy and hormone therapy initially reduced the severity of the cancer, but tests in August 2006 revealed it had returned with force. Two courses of chemotherapy did not work and Mr Bush, who worked as a banker before he became ill, was referred to take part in the Royal Marsden trial of abiraterone. After just a week, Mr Bush started to see a drop in his PSA levels - a marker for prostate cancer. And within six weeks, the 50-year-old from London had gone from taking the maximum dose of painkillers for his bone pain to taking none at all. "Last year I was in severe pain because of my prostate cancer, which had spread to my bones," the father of two said. "Chemotherapy and other treatments... [read full story]